Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Structural Benefits of SC Abatacept in RA
NCT01351480Phase 3Completed
- Sponsor
- Arthritis & Rheumatic Disease Specialties, P.A.
- Start
- Jun 2011
- Primary completion
- Jan 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of abatacept in rheumatoid arthritis (RA), sponsored by Arthritis & Rheumatic Disease Specialties, P.A.. Started Jun 2011; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01351480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01351480.